Identification and characterization of circulating human transitional B cells

被引:447
作者
Sims, GP
Ettinger, R
Shirota, Y
Yarboro, CH
Illei, GG
Lipsky, PE
机构
[1] NIAMSD, Intramural Res Program, Autoimmun Branch, Bethesda, MD 20892 USA
[2] NIAMSD, Off Clin Director, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood-2004-11-4284
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Murine B-cell development begins in bone marrow and results in the generation of immature transitional B cells that transit to the spleen to complete their maturation. it remains unclear whether the same developmental pathway takes place in humans. Using markers characteristic of human bone marrow immature B cells, we have identified a population of circulating human B cells with a phenotype most similar to mouse transitional type I (T1) B cells, although these human counter-parts express CD5. These cells die rapidly in culture, and B-cell activation factor member of the tumor necrosis factor (TNF) family (BAFF) does not effect their survival regardless of B-cell receptor (BCR) stimulation. In contrast, bone marrow stromal cells or interleukin-4 (IL-4) significantly enhanced their survival. In the presence of T-cell signals provided by IL-4 or CD40 ligation, BCR stimulation can induce progression into cell cycle. Interestingly, circulating B cells that phenotypically and functionally resemble murine T2 B cells are found in cord blood and adult peripheral blood, suggesting that B-cell maturation may not be restricted to the spleen. Notably, increased proportions of T1 B cells were found in blood of patients with systemic lupus erythematosus (SLE), although bone marrow production and selection appeared to be normal.
引用
收藏
页码:4390 / 4398
页数:9
相关论文
共 70 条
  • [21] CD5 maintains tolerance in anergic B cells
    Hippen, KL
    Tze, LE
    Behrens, TW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) : 883 - 889
  • [22] INTERLEUKIN-4 ENHANCES ANTI-IGM STIMULATION OF B-CELLS BY IMPROVING CELL VIABILITY AND BY INCREASING THE SENSITIVITY OF B-CELLS TO THE ANTI-IGM SIGNAL
    HODGKIN, PD
    GO, NF
    CUPP, JE
    HOWARD, M
    [J]. CELLULAR IMMUNOLOGY, 1991, 134 (01) : 14 - 30
  • [23] Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus
    Jacobi, AM
    Odendahl, M
    Reiter, K
    Bruns, A
    Burmester, GR
    Radbruch, A
    Valet, G
    Lipsky, PE
    Dörner, T
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (05): : 1332 - 1342
  • [24] KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441
  • [25] Kantor AB, 1997, J IMMUNOL, V158, P1175
  • [26] THE DEVELOPMENT AND REPERTOIRE OF B-1 CELLS (CD5 B-CELLS)
    KANTOR, AB
    [J]. IMMUNOLOGY TODAY, 1991, 12 (11): : 389 - 391
  • [27] Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes:: CD27 as a general marker for somatically mutated (memory) B cells
    Klein, U
    Rajewsky, K
    Küppers, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) : 1679 - 1689
  • [28] Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen
    Kruetzmann, S
    Rosado, MM
    Weber, H
    Germing, U
    Tournilhac, O
    Peter, HH
    Berner, R
    Peters, A
    Boehm, T
    Plebani, A
    Quinti, I
    Carsetti, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (07) : 939 - 945
  • [29] Germinal center founder cells display propensity for apoptosis before onset of somatic mutation
    Lebecque, S
    deBouteiller, O
    Arpin, C
    Banchereau, J
    Liu, YJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) : 563 - 571
  • [30] Lentz VM, 1998, J IMMUNOL, V160, P3743